Colchicine-derived anticancer molecules with up to 2000-fold selectivity for cancer cells over normal cells
A drug discovery research team led by Assoc. Prof. Dr. Tanatorn Khotavivattana from the Department of Chemistry, Faculty of Science, Chulalongkorn University has developed a new class of anticancer molecules by modifying the structure of colchicine, a natural compound known to inhibit cell division by binding to the tubulin protein that forms microtubules inside cells. …










